5 completed, 4 unknown, 2 recruiting, 2 terminated. 16 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 16 | Completed 5, Unknown 4, Recruiting 2, Terminated 2, Withdrawn 2, Active not recruiting 1 |
Follow Desogestrel: new trials by email Literature Review of Desogestrel trials Research Report on Desogestrel
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PPOS (Progestin Primed Ovarian Stimulation) and Corifollitropin Alfa (CFA) Cross-over Study Elonva®, Puregon®, Orgalutran® - Ovarian Stimulation, Quality of Life | Phase 4 | Recruiting | University Hospital, Ghent | 60 | 2025-01-27 | 2025-12-26 |
| Oral Contraceptive Pill (OCP) Pharmacogenomics Desogestrel / Ethinyl Estradiol Pill - Contraception, Pharmacogenomic Drug Interaction | Phase 4 | Recruiting | Yale University | 700 | 2024-10-29 | 2026-07-16 |
| Desogestrel-containing COCP Pharmacokinetic Validation Study Desogestrel and Ethinyl Estradiol Tablets - Contraception | Phase 4 | Completed | University of Colorado, Denver | 22 | 2021-09-10 | 2025-05-30 |
| Desogestrel Versus GnRH Antagonist in IVF/ICSI Desogestrel 0.075 MG, Orgalutran - IVF, Infertility | Phase 4 | Unknown | Casa di Cura Privata Villa Mafalda | 165 | 2020-10-01 | 2021-01-28 |
| Traditional Chinese Medicine, Western Medicine and Low-level Light Therapy(LLLT) for Primary Dysmenorrhea(PD) low level light therapy, DING KUN DAN, Simulated drug of DING KUN DAN - Primary Dysmenorrhea, Traditional Chinese Medicine | Phase 4 | Unknown | Peking Union Medical College Hospital | 480 | 2019-06-22 | 2019-06-25 |
| Desogestrel (DSG) and Corifollitropin(FSH-CTP) Alfa for Ovarian Stimulation in Donors FSH-CTP + DESOGESTREL - Infertility | Phase 4 | Withdrawn | Fundacion Dexeus | 2016-05-01 | 2018-09-05 | |
| Effects of Oral vs. Non-oral Contraceptives on the GH/IGF-1 Axis Combined Oral Contraceptive, Transdermal Contraceptive, Contraceptive Vaginal Ring - Bone; Disorder, Development and Growth | Phase 4 | Completed | Penn State University | 60 | 2015-01-01 | 2020-03-09 |
| Assessing the Impact of Contraceptives on Bone Health Using 41Ca Combined Oral Contraceptive (COC), Contraceptive Vaginal Ring (CVR) - Other Disorders of Bone Development and Growth | Phase 4 | Active not recruiting | Penn State University | 6 | 2015-01-01 | 2026-07-06 |
| NuvaRing Versus Marvelon in the Coordination of In Vitro Fertilization Cycles Contraceptives, Oral, Contraceptive, Vaginal ring - Infertility | Phase 4 | Terminated | Clinique Ovo | 7 | 2012-07-01 | 2015-07-27 |
| Study of the Efficacy of Dienogest in the Treatment of Uterine Leiomyomas When Compared to Desogestrel and Goserelin Dienogest, Goserelin, Desogestrel - Uterine Leiomyoma | Phase 4 | Terminated | University of Sao Paulo | 14 | 2012-01-01 | 2020-08-13 |
| Is Cerazette Use Before Nexplanon Insertion Predictive for Bleeding Pattern? Desogestrel 75 micrograms POP (Cerazette), Etonogestrel 68 mg implant (Nexplanon), Etonogestrel 68 mg subdermal implant - Bleeding | Phase 4 | Unknown | VL-Medi Oy | 90 | 2011-09-01 | 2011-09-22 |
| New Treatments for Troublesome Bleeding in Implanon Users Marvelon - Menstrual Problem | Phase 4 | Unknown | Family Planning Association New South Wales | 200 | 2011-07-01 | 2011-06-29 |
| Premenstrual Symptoms Treatment Comparing Between Oral Contraceptives Containing Desogestrel and Drospirenone EE 20 microgram with desogestrel 150 mg, EE 20 microgram with drospirenone 3 mg - Premenstrual Syndrome | Phase 4 | Completed | Chulalongkorn University | 90 | 2011-06-01 | 2012-03-14 |
| Oral Microdose Lupron Versus Luteal Estradiol Trial in Poor Responder In Vitro Fertilization (IVF) Patients Oral contraceptive pill and microdose lupron, E2 patch/antagonist - Infertility | Phase 4 | Withdrawn | Weill Medical College of Cornell University | 2009-01-01 | 2013-06-25 | |
| An Efficacy and Safety Study Comparing Oral Contraceptive Containing Norgestimate or Desogestrel for Acne Treatment Ethinyl estradiol/Norgestimate (EE/NGM), Ethinyl estradiol/Desogestrel (EE/DSG) - Acne Vulgaris | Phase 4 | Completed | Janssen-Cilag Ltd.,Thailand | 201 | 2008-12-01 | 2013-06-19 |
| Predictive Factors for Ovarian Stimulation Using a Fixed Daily Dose of 200 IU Recombinant FSH (Study 142003)(P05696) Marvelon - Infertility | Phase 4 | Completed | Organon and Co | 442 | 2006-10-01 | 2022-02-04 |
Infertility (5) · Acne Vulgaris (1) · Hemorrhage (1) · Menstruation Disturbances (1) · Myofibroma (1) · Premenstrual Syndrome (1)
Penn State University (2) · Casa di Cura Privata Villa Mafalda (1) · Chulalongkorn University (1) · Clinique Ovo (1) · Family Planning Association New South Wales (1) · Fundacion Dexeus (1) · Janssen-Cilag Ltd.,Thailand (1) · Organon and Co (1) · Peking Union Medical College Hospital (1) · University Hospital, Ghent (1) · University of Colorado, Denver (1) · University of Sao Paulo (1) · VL-Medi Oy (1) · Weill Medical College of Cornell University (1) · Yale University (1)
United States (5) · Thailand (2) · Australia (1) · Belgium (1) · Canada (1) · China (1) · Finland (1) · Italy (1) · Spain (1)
Mary Jane De Souza, PhD (2) · Aaron M Lazorwitz, MD, PhD (1) · Dan Apter, Docent (1) · Edith Weisberg, MB BS MM (1) · Jacques Kadoch, MD (1) · Jirath Wichianpitaya, M.D. (1) · Luiz Gustavo O Brito, MD, PhD (1) · Surasak Taneepanichskul, M.D. (1) · Zev Rosenwaks, M.D. (1)
PMID 21954280, PMID 24903202, PMID 25074072, PMID 32612574, PMID 35028764, PMID 37331464, PMID 39615778
2023 (1), R01HD111436 (1)